Cited by 1,108Mass Spectrometry Techniques and ApplicationsIon-surface interactions and analysisAdvanced Proteomics Techniques and Applications

Multiplexed ion beam imaging of human breast tumors

Open access
Angelo, Michael, Bendall, Sean C, Finck, Rachel, Hale, Matthew B, Hitzman, Chuck, Borowsky, Alexander D, Levenson, Richard M, Lowe, John B +4 more·2014·Nature Medicine

Abstract

Immunohistochemistry (IHC) is a tool for visualizing protein expression that is employed as part of the diagnostic workup for the majority of solid tissue malignancies. Existing IHC methods use antibodies tagged with fluorophores or enzyme reporters that generate colored pigments. Because these reporters exhibit spectral and spatial overlap when used simultaneously, multiplexed IHC is not routinely used in clinical settings. We have developed a method that uses secondary ion mass spectrometry to image antibodies tagged with isotopically pure elemental metal reporters. Multiplexed ion beam imaging (MIBI) is capable of analyzing up to 100 targets simultaneously over a five-log dynamic range. Here, we used MIBI to analyze formalin-fixed, paraffin-embedded human breast tumor tissue sections stained with ten labels simultaneously. The resulting data suggest that MIBI can provide new insights into disease pathogenesis that will be valuable for basic research, drug discovery and clinical diagnostics.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nm.3488

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • At least two platforms now allow high-dimensional tissue imaging with antibodies, detecting over 40 parameters in a single section.

    “There are now at least two platforms that enable high-dimensional tissue imaging with antibodies, allowing over 40 parameters to be simultaneously detected in a single section (Angelo et al., 2014; Giesen et al., 2014).”

    From Protein Barcodes Enable High-Dimensional Single-Cell CRISPR Screens (2018) · cites this paper as Angelo et al., 2014

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Angelo, M., Bendall, S. C., Finck, R., Hale, M. B., Hitzman, C., Borowsky, A. D., Levenson, R. M., Lowe, J. B., Liu, S. D., Zhao, S., Natkunam, Y., & Nolan, G. P.
Affiliations
  • University of California, San Francisco (US)
  • Stanford University (US)
  • University of California Davis Medical Center (US)
  • Genentech (US)
  • Stanford Medicine (US)
Corresponding author
Nolan, Garry P
Venue
Nature Medicine
Published
2014-03-02
Volume
20
Issue
4
Pages
436-442
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W2043565262
Cited by
1,108
References
34
Citations by year
2026: 88 · 2025: 86 · 2024: 121 · 2023: 122 · 2022: 114 · 2021: 147 · 2020: 92 · 2019: 89 · 2018: 75 · 2017: 59 · 2016: 53 · 2015: 41 · 2014: 19
FWCI
24.55
Type
journal article
Language
en
Open access
Locations
  • Nature Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • National Science Foundation (0922648, AI057229)
  • U.S. Department of Defense
  • California Institute for Regenerative Medicine (RB2-01592, DR1-01477)
  • Damon Runyon Cancer Research Foundation (DRG-2017-09)
  • European Commission
  • National Institutes of Health (1s10od016318-01, N01-HV-00242, 5u54ca143907-05, HHSN272200700038C, n01hv28183-13-0-0, 5U54 CA143907, AI057229)
  • Genentech
  • National Heart, Lung, and Blood Institute (N01 HV028183, N01-HV 00242, HHSN268201000034C)
  • National Eye Institute (PN2EY018228)
  • National Cancer Institute (U54CA119367, P50CA114747, 5R25CA11868107, 5U54 CA143907, U54CA149145, U54-CA-143907, RFA CA 09-011, R25CA118681, R01CA130826, P01CA034233, RFA CA 09-009, P30CA093373, R01 CA120525)
  • National Institute of General Medical Sciences (K99GM104148, R00GM104148)
  • National Institute of Allergy and Infectious Diseases (U19AI100627, R01AI035304, R01AI073724, HHSN272200700038C, P01AI036535, U19AI057229)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R21DK073928)
  • National Center for Research Resources (S10RR027431, S10RR027582)
Topics
  • Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
  • Physical Sciences › Engineering › Computational Mechanics › Ion-surface interactions and analysis
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
Keywords
MIBI, breast tumors, secondary ion mass spectrometry, formalin-fixed paraffin-embedded tissue, multiplex immunohistochemistry, antibody labeling, tumor markers
MeSH terms
Breast Neoplasms, Female, Humans, Immunohistochemistry, Receptors, Progesterone, Mass Spectrometry, Biomarkers, Tumor, Erb-b2 Receptor Tyrosine Kinases, Estrogen Receptor alpha

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review